| NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition M Hinz, D Krappmann, A Eichten, A Heder, C Scheidereit, M Strauss Molecular and cellular biology, 1999 | 1163 | 1999 |
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. RC Bargou, F Emmerich, D Krappmann, K Bommert, MY Mapara, ... The Journal of clinical investigation 100 (12), 2961-2969, 1997 | 1008 | 1997 |
| IκB kinase complexes: gateways to NF-κB activation and transcription C Scheidereit Oncogene 25 (51), 6685-6705, 2006 | 876 | 2006 |
| The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus C Scheidereit, S Geisse, HM Westphal, M Beato Nature 304 (5928), 749-752, 1983 | 701 | 1983 |
| Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia SA Slaugenhaupt, A Blumenfeld, SP Gill, M Leyne, J Mull, MP Cuajungco, ... The American Journal of Human Genetics 68 (3), 598-605, 2001 | 680 | 2001 |
| The IκB kinase complex in NF‐κB regulation and beyond M Hinz, C Scheidereit EMBO reports 15 (1), 46-61, 2014 | 571 | 2014 |
| NF-κB and the innate immune response EN Hatada, D Krappmann, C Scheidereit Current opinion in immunology 12 (1), 52-58, 2000 | 471 | 2000 |
| Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB S Mathas, M Hinz, I Anagnostopoulos, D Krappmann, A Lietz, F Jundt, ... The EMBO journal 21 (15), 4104-4113, 2002 | 466 | 2002 |
| Activation of NF‐kappa B in vivo is regulated by multiple phosphorylations. M Naumann, C Scheidereit The EMBO journal 13 (19), 4597-4607, 1994 | 462 | 1994 |
| High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells RC Bargou, C Leng, D Krappmann, F Emmerich, MY Mapara, K Bommert, ... | 423 | 1996 |
| Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro C Scheidereit, A Heguy, RG Roeder Cell 51 (5), 783-793, 1987 | 415 | 1987 |
| A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein C Scheidereit, JA Cromlish, T Gerster, K Kawakami, CG Balmaceda, ... Nature 336 (6199), 551-557, 1988 | 403 | 1988 |
| Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters D Von Der Ahe, S Janich, C Scheidereit, R Renkawitz, G Schütz, M Beato Nature 313 (6004), 706-709, 1985 | 403 | 1985 |
| Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter … K Kawakami, C Scheidereit, RG Roeder Proceedings of the National Academy of Sciences 85 (13), 4700-4704, 1988 | 401 | 1988 |
| The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators R Dechend, F Hirano, K Lehmann, V Heissmeyer, S Ansieau, FG Wulczyn, ... Oncogene 18 (22), 3316-3323, 1999 | 395 | 1999 |
| Reciprocal requirements for EDA/EDAR/NF-κB and Wnt/β-catenin signaling pathways in hair follicle induction Y Zhang, P Tomann, T Andl, NM Gallant, J Huelsken, B Jerchow, ... Developmental cell 17 (1), 49-61, 2009 | 379 | 2009 |
| Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells U Kordes, D Krappmann, V Heissmeyer, WD Ludwig, C Scheidereit Leukemia 14 (3), 399-402, 2000 | 370 | 2000 |
| Overexpression of I kappa B alpha without inhibition of NF-κB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells F Emmerich, M Meiser, M Hummel, G Demel, HD Foss, F Jundt, S Mathas, ... Blood, The Journal of the American Society of Hematology 94 (9), 3129-3134, 1999 | 369 | 1999 |
| Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells D Krappmann, F Emmerich, U Kordes, E Scharschmidt, B Dörken, ... Oncogene 18 (4), 943-953, 1999 | 367 | 1999 |
| The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. EN Hatada, A Nieters, FG Wulczyn, M Naumann, R Meyer, G Nucifora, ... Proceedings of the National Academy of Sciences 89 (6), 2489-2493, 1992 | 362 | 1992 |
